To further determine whether macrophage-derived LGMN could affect GBM cell proliferation, GBM cells (e.g., SF763, LN229, U87, and CT2A cells) were treated with the CM collected from THP1 and Raw264.7 macrophages with or without LGMN knockdown. Here, LGMN is linked to glioblastoma.